Moerman ANN SRL
0.1 FTEThe score of Moerman ANN shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +53 % Total assets +31 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Moerman ANN's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 81,673 € | ||||
| Equity | 619,029 € | ||||
| Cash | 190,281 € | ||||
| EBITDA | 128,944 € | ||||
| Total assets | 819,356 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Apr 2026
- Year ended 31 Dec 2024filed on 06 Aug 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Moerman ANN's financial analysis
- Solvency75.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Moerman ANN
Moerman ANN's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0808.468.175
- VAT number
- BE0808468175
- Peppol
- Registered · 0208:0808468175 · as of 27 Oct 2026
- Legal form
- SRL
- Incorporated
- 16 Dec 2008
- Registered office
- 8300 Knokke-Heist
- Size
- Micro · 0.1 FTE
- Latest accounts
- 2025 · filed on 29 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Moerman ANN (SRL) has been based in Knokke-Heist since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 81,673 € and equity of 619,029 €; its revenue is not published. With 0.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 75.6%, above the median of its sector (44.2%).
Companies similar to Moerman ANN
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Petre Retail sale of pharmaceutical products Éghezée · balance sheet 819,584 €
- Apotheek Twee Neten Retail sale of pharmaceutical products Lier · balance sheet 819,103 €
- Phardup Retail sale of pharmaceutical products Etterbeek · balance sheet 817,511 €
- Cobra Apotheek Dessel Retail sale of pharmaceutical products Dessel · balance sheet 813,901 €
- Heylen Farma Retail sale of pharmaceutical products Aarschot · balance sheet 826,841 €
- AllGor Retail sale of pharmaceutical products Kortrijk · balance sheet 810,045 €
- Farma Waelput Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €1.01m
- Vandevelde Retail sale of pharmaceutical products Tielt · balance sheet 829,943 €
Frequently asked questions about Moerman ANN
What is the revenue of Moerman ANN?
Moerman ANN files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Moerman ANN?
In Belgium, the VAT number is the company number prefixed with BE: BE0808468175 for Moerman ANN, if the company is VAT-registered. Its company number (CBE) is 0808.468.175.
Where is the registered office of Moerman ANN?
According to the CBE register, the registered office of Moerman ANN is in 8300 Knokke-Heist.
What is the equity of Moerman ANN?
At the close of the 2025 financial year, the equity of Moerman ANN amounts to 619,029 €, a solvency of 75.6% of total assets.
How many people work at Moerman ANN?
0.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Moerman ANN?
The register lists 1 active mandates at Moerman ANN. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Moerman ANN
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →